Augmenting Technological advancements Genome Editing Tools is Driving Synthetic Biology

Download PDF Brochure: https://bit.ly/3f6flKv

Synthetic biology is a multidisciplinary approach that use various tools and techniques of biotechnology to alter the biological systems. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms.

The advancement in the synthetic biology has led to the faster and easier design of DNA, and helped exponentially reducing the cost of DNA sequencing and synthesis.

According to a new market research study titled ‘Oligonucleotide Synthesis market - Global Analysis and Forecasts by Product, Application and End User. The global oligonucleotide synthesis market is expected to reach US$ 3,971.7 Mn in 2027 from US$ 1,584.2 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027. The report highlights the trends prevalent in the global oligonucleotide synthesis market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to increasing investments for synthetic biology and technological advancements genome editing tools.

Advancement in the field of biotechnology has equally enhanced the synthetic biology. Many industry players have come up with innovative types of synthetic biology in last few years. Synthetic biology is a multidisciplinary approach that use various tools and techniques of biotechnology to alter the biological systems. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms. The advancement in the synthetic biology has led to the faster and easier design of DNA, and helped exponentially reducing the cost of DNA sequencing and synthesis.

The technological advancement as headed emergence of the New Bioeconomy, which is the replacement of petrochemical-based manufacturing and fermentation-based manufacturing products. In addition, the investments from public and private investors are rising for the synthetic biology. The rise in the investment are enabling technological developments and standard biological parts.

Advancement in synthetic biology has added various solution for most of the industries such as, pharmaceutical, petrochemical, food and agriculture among others. These technological advancement are likely to grow the market in near future.

Global oligonucleotide synthesis market, based on the end user was segmented into, academic research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and other end users. Academic research institutes segment is anticipated to grow at a CAGR of 11.2% during the forecast period. The academic & research institutes are getting funds from the various organizations for the research and development sector for the betterment of gene synthesis Moreover, many of the organizations have formed due to the partnerships between various organizations and universities for research in the transformation of scientific technologies to make the life-saving treatments for patients.